EVE 0.00% 0.1¢ eve health group limited.

Ann: Eagle Plans to Significantly Expand China Distribution, page-31

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,270 Posts.
    lightbulb Created with Sketch. 653
    A quick look through EVE's announcements over the past year or so will show that this company is on the verge of a quite dramatic lift in it's performance, with considerable earnings scope from its Meluka/Jenbrook interests and its Omni/EHH interests.

    In case you missed them, I've included a couple of lasts year's announcements concerning Meluka/Jenbrook.


    An organic tea tree farm in New South Wales has received a $1.49 million investment to help develop medical cannabis honey.
    Jenbrook supplies raw tea tree oil and honey products to the US through Naturally Aust Product. Next month, it's expected to hit $1.6m annualised monthly revenue, a 100% increase from June 2016.
    The company has also been exploring a medical hemp honey, produced by bees pollinating on the nectar of medicinal cannabis plants. It's working with Southern Cross University on research into its health benefits. EVE Investments has kicked in the $1.49 million to help get the product to market.
    In return, EVE - an ASX-listed technology investment company - will acquire a 50% interest in Jenbrook.
    Jenbrook is based in Alstonville in the NSW Northern Rivers region. Subject to the transaction, its assets also include Jendale and Robyndale tea tree plantations in the heart of the Bungawalbyn Valley Basin, and the patented extraction technique used to produce high potency tea tree oil.
    The plantations are also a source of melaleuca honey, and Jenbrook is currently validating a production process which is expected to yield honey with "superior antibacterial properties" to manuka honey.
    It claims the "meluka" honey has potential as a treatment for "certain human diseases".
    "The business is at a very exciting point and is uniquely positioned to disrupt the approximate $2.1 billion global manuka honey market," EVE's investments director Ben Rohr said.

    The acquisition will be facilitated through the creation of a new company (NewCo) that will be a 50/50 joint venture between EVE Investments and Jenbrook
    FacebookTwitterLinkedInPrintEmail

    EVE Investments (ASX: EVE) today announced the subsidiary of its joint venture company Meluka Health has produced Australia’s first 100% organic hemp seed honey.
    Meluka’s wholly owned subsidiary Medic Honey completed formulation and production of the product, combining raw honey and hemp seed, which is said to have a concentrated balance of proteins, essential fats, vitamins and enzymes and a relative absence of sugar, starches and saturated fats.
    According to EVE, this combination creates a honey with “truly unique health benefits and an exceptional flavour profile”.
    Branding is expected to be completed in the next month, with the honey being ready for wholesale distribution by the end of this year. Direct consumer distribution will start in the first quarter of 2018, EVE reported.
    Medic Honey will market the product itself into the Australian market, selling it under the Meluka brand. In the US market, the company has appointed Naturally Australian Products to distribute the honey to wholesalers and manufacturers.
    “As a Californian company we have seen first-hand the growth in demand for hemp and cannabis related products,” Naturally Australian Product chief executive Robyn Ingersole said.
    “When this is combined with the demand for organic Australian honey, we think this product is well suited to meet this consumer interest.”
    EVE is acquiring a 50% interest in Meluka Health, with the remaining half retained by NSW tea tree farming company Jenbrook Pty Ltd. Meluka wholly owns Medic Honey, as well as a tea tree manufacturing and distribution business, EcoBotanicals.
    Shares in EVE were up 14% following the news in midday trade.
    Hemp food products

    In April this year, hemp food products were approved for human consumption in both Australia and New Zealand. Prior to this, all species of cannabis were banned from being added or sold as food.
    Unlike some other varieties of cannabis, hemp contains no or very low levels of THC (the psychoactive substance found in marijuana) and therefore does not have therapeutic benefits like the extracts now being researched and marketed for medicinal purposes. However, hemp seeds contain protein, vitamins, minerals and polyunsaturated fats including omega-3 fatty acids.
    The legal cannabis market is still quite new, with Australia only receiving legislative approval for medical use of the product in 2016. However, investment in the cannabis industry is growing quickly especially in the US and Canadian markets.
 
watchlist Created with Sketch. Add EVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.